Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway — Michael Maes (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
Shared by
Michael Maes
University of Electronic Science and Technology of China
Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
Article
2012
en
Authors
Michael Maes
University Of Electronic Science & Technology Of China
WR
Winfried Rief
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2012
Inflammation-Related Disorders in the Tryptophan Catabolite Pathway in Depression and Somatization
George Anderson
,
Michael Maes
,
Michael Berk
Article
2022
The Tryptophan Catabolite or Kynurenine Pathway’s Role in Major Depression
Abbas F. Almulla
,
Michael Maes
Article
2016
Overlapping the Tryptophan Catabolite (TRYCAT) and Melatoninergic Pathways in Alzheimer';s Disease
Michael Maes
,
George Anderson
Preprint
2023
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway
Hussein Kadhem Al‐Hakeim
,
Anwar Khairi Abed
,
Abbas F. Almulla
,
Shatha Rouf Moustafa
,
Michael Maes
Letter
2023
Anxiety due to Long COVID is partially driven by activation of the tryptophan catabolite (TRYCAT) pathway
Hussein Kadhem Al‐Hakeim
,
Anwar Khairi Abed
,
Abbas F. Almulla
,
Shatha Rouf Moustafa
,
Michael Maes
Discussion(0)
No comments yet. Be the first to comment.